tiprankstipranks
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
PremiumPress ReleasesAC Immune to Regain Global Rights to Crenezumab and Semorinemab
3M ago
AC Immune provides update on program progress, says key milestones in 2024
PremiumThe Fly
AC Immune provides update on program progress, says key milestones in 2024
4M ago
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer’s and Parkinson diseases
PremiumPress Releases
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer’s and Parkinson diseases
4M ago
AC Immune appoints Madiha Derouazi as CSO, Christopher Roberts as CFO
PremiumThe FlyAC Immune appoints Madiha Derouazi as CSO, Christopher Roberts as CFO
5M ago
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
PremiumPress Releases
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
5M ago
AC Immune reports Q3 EPS (18c), consensus 3c
PremiumThe Fly
AC Immune reports Q3 EPS (18c), consensus 3c
6M ago
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
PremiumPress ReleasesAC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
7M ago
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
PremiumPress Releases
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
8M ago
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
PremiumPress Releases
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100